Avid Bioservices (DE:TEHP)
FRANKFURT:TEHP

Avid Bioservices Stock Price & Analysis

0 Followers

TEHP Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€11.01 - €26.80
Previous Close€14.92
Volume0.00
Average Volume (3M)64.00
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$115.14M
Total Debt (Recent Filing)$182.03M
Price to Earnings (P/E)N/A
Beta1.50
Next EarningsDec 06, 2022
EPS Estimate<€0.01
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)N/A
Shares Outstanding62,167,454
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. Volume64
Price to Book (P/B)5.70
Price to Sales (P/S)9.33
Price to Cash Flow (P/CF)101.60
P/FCF Ratio-20.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside35.52% Upside
Rating ConsensusModerate Buy
AlphaN/A
Number of Analyst Covering1


Financials


TEHP FAQ

What was Avid Bioservices’s price range in the past 12 months?
Avid Bioservices lowest stock price was €11.01 and its highest was €26.80 in the past 12 months.
    What is Avid Bioservices’s market cap?
    Currently, no data Available
    When is Avid Bioservices’s upcoming earnings report date?
    Avid Bioservices’s upcoming earnings report date is Dec 06, 2022 which is today.
      How were Avid Bioservices’s earnings last quarter?
      Avid Bioservices released its earnings results on Sep 06, 2022. The company reported €0.045 earnings per share for the quarter, beating the consensus estimate of €0.033 by €0.011.
        Is Avid Bioservices overvalued?
        According to Wall Street analysts Avid Bioservices’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Avid Bioservices pay dividends?
          Avid Bioservices does not currently pay dividends.
          What is Avid Bioservices’s EPS estimate?
          Avid Bioservices’s EPS estimate is <€0.01.
            How many shares outstanding does Avid Bioservices have?
            Currently, no data Available
            What happened to Avid Bioservices’s price movement after its last earnings report?
            Avid Bioservices reported an EPS of €0.045 in its last earnings report, beating expectations of €0.033. Following the earnings report the stock price went down -0.682%.
              Which hedge fund is a major shareholder of Avid Bioservices?
              Among the largest hedge funds holding Avid Bioservices’s share is Driehaus Capital Management LLC. It holds Avid Bioservices’s shares valued at 10M.

                ---

                Avid Bioservices Stock Smart Score

                1
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -47.90%
                12-Months-Change

                Fundamentals

                Return on Equity
                109.94%
                Trailing 12-Months
                Asset Growth
                66.79%
                Trailing 12-Months
                The Avid Bioservices Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Avid Bioservices

                Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                RegenXBio
                Iovance Biotherapeutics
                Crinetics Pharmaceuticals
                Viridian Therapeutics
                Avid Bioservices

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis